|
|
|
|
|
| For Hybrid Trials, Have Some Faith … In Sites | From The Editor | By Dan Schell, chief editor, Clinical Leader | Noelle Gaskill believes the key to regulatory success with a DCT is to not force a bunch of tech onto sites, but instead, choose those that already have the needed technology and experience and then let them do what they do best – execute on the trial. |
|
|
| Empowering Clinical Research Sites And Sponsors In Patient-Centric Era | e-book | By Kerry Gorman, Colleen Gosa, Kylie Scheideler, Katy Preciado, and Rebecca Sayers, IQVIA Research & Development Solutions | Strategic collaboration between trial sites and sponsors plays a critical role in fostering patient-centricity within Decentralized Clinical Trials (DCTs). |
|
|
|
|
|
| The Health Equity Congress (May 5-7, Atlanta) is the premier gathering where pharma, biotech, and med device leaders unite to drive organizational transformation in health equity. Industry pioneers share data-backed strategies to enhance patient recruitment, accessibility, and community engagement. Gain critical tools to scale representation efforts, build trust, and integrate equity into corporate strategies. This one-of-a-kind event turns competitors into collaborators, accelerating sustainable health equity. |
|
|
|
| A Tool To Tackle The Risk Of Uninformative Trials | Guest Column | By Thomas Wood, Fast Data Science | Uninformative trials hinder progress in clinical practice, policy decisions, and further research. Fast Data Science developed a free risk tool to help pharma companies avoid them. |
|
|
|
| Improving The Patient Experience In Clinical Research | Article | By Mike Stratton, CSSi - An Elixia Company | To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often. |
|
|
|
| Ensuring The Efficacy Of Probiotic Products | Article | Ropack Pharma Solutions | Without proper handling and packaging, the efficacy of probiotics can be compromised at any point in the packaging, storage, and transportation process, impacting shelf life and effectiveness. |
|
|
|
| Q&A With Novartis And IQVIA Study Start-Up Leaders | Q&A | Origin: Novartis, IQVIA Technologies | The industry is measuring longer cycle times between protocol approval and site activation. Experts from Novartis and IQVIA share creative solutions to combat this trend and accelerate trial timelines. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
